Monoclonal rat anti-mouse brain antibody detects Abelson murine leukemia virus target cells in mouse bone marrow

Cell
|May 1, 1980
PubMed

Insights

Researchers identified a novel surface antigen on bone marrow cells targeted by Abelson murine leukemia virus (A-MuLV). This discovery aids in understanding A-MuLV infection and developing targeted therapies.

Area of Science:

  • Immunology
  • Virology
  • Hematology

Background:

  • Abelson murine leukemia virus (A-MuLV) infects specific bone marrow cells.
  • Targeting these cells is crucial for understanding viral pathogenesis and developing therapies.

Purpose of the Study:

  • To characterize a monoclonal antibody recognizing a surface antigen on A-MuLV target cells.
  • To determine the expression profile of this antigen on various hematopoietic cells.

Main Methods:

  • Monoclonal antibody production and characterization.
  • Complement-mediated cell lysis assays.
  • Flow cytometry analysis of antigen expression.

Main Results:

  • A monoclonal antibody was developed that detects a specific surface antigen on A-MuLV target bone marrow cells.
  • Antibody treatment with complement eliminated >95% of A-MuLV-transformed foci in vitro.
  • The antigen is present on A-MuLV-transformed lymphoid cells, thymocytes, and some peripheral lymphocytes, but not on pluripotent hematopoietic stem cells.

Conclusions:

  • The identified antigen is a potential marker for A-MuLV target cells.
  • This antigen is not a viral product and is not exclusive to the BALB/c genome.
  • The antibody offers a tool for studying A-MuLV infection and potentially for therapeutic interventions.

Related Concept Videos